Oral Solid Dose

The oral solid dose (OSD) market is $335 billon with a low growth rate of less than one percent over the last five years. It is causing a shift in how companies plan and execute the development and manufacturing of OSD drug products. Navigating a complex regulatory environment, analytical data, process development and optimization, and on-time delivery are all vital to the success of your OSD drug product. Thermo Fisher Scientific provides a range of flexible OSD solutions that can help you easily address your small molecule’s unique needs and challenges, while being backed by a global network and industry experts.

Thermo Fisher Scientific

Share content on email